Actinic cheilitis: a case report and a review of the literature

Authors

  • Dasaiev M. Dutra Federal University of Paraíba
  • Maria Auxiliadora G do Nascimento Federal University of Paraíba
  • Maria Sueli Marques Soares Federal University of Paraíba

DOI:

https://doi.org/10.15448/http://dx.doi.org/10.15448/1980-6523.2016.1.18191

Keywords:

Cheilitis, Carcinoma, Inflammation

Abstract

Objective: This article presents a case report of actinic cheilitis with an acute inflammatory process and need for anti- inflammatory treatment.
Case Report: Triamcinolone acetonide in Orabase was prescribed 3 times a day for 15 days, and the patient was advised to use sunscreen and hats. After 7 days, there was a significant improvement in the acute phase and the patient was kept under observation.
Conclusion: It is emphasized that it is important to intervene in the evolution of the inflammatory process in premalignant lesions in order to prevent its long-term maintenance.

References

Domaneschi C, Santos SG, Navarro CM, Massucato SEM. Actinic cheilitis, actinic association between radiation and trauma. RGO. 2003;51:101-4.

Wood NH, Khammissa R, Meyerov R, Lemmer J, Feller L. Actinic cheilitis: a case report and a review of the literature. Eur J Dent. 2011;5:101-6.

Rossoe EWT, Tebcherani AJ, Sittart JA, Pires MC. Queilite actínica: avaliação comparativa estética e funcional entre as vermelhectomias clássica e em W-plastia. An Bras Dermatol. 2011;86(1):65-73.

Martins MD, Marques LO, Martins MAT, Bussadori SK, Fernandes KPS, Kristianne PS. Queilite actínica: relato de caso clínico. ConScientiae Saúde. 2007;6:105-10.

Miranda AMO, Ferrari TM, Calandro TLL. Queilite actínica : aspectos clínicos e prevalência encontrados em uma população rural do interior do brasil. Revista Saúde e Pesquisa. 2011;4:67-72.

Savage NW, Mckay C, Faulkner C. Actinic cheilitis in dental practice. Aust Dent J. 2010;55:78-84.

Kaugers GE, Pillon T, Svirsk J, Pages DG, Bruns JC. Actinic cheilitis: a review of 52 cases. Oral surg oral med oral pathol oral radiol oral endod. 1999; 88:181-6.

Mantovani A, Allavana P, Sica A, Balkwill F. Cancer- related inflammation. Nature. 2008;454:436-44.

Freitas MCA, Ramalho LMP, Xavier FCA, Moreira ALG, Reis SRA. p53 and mdm2 protein expression in actinic cheilitis. J Appl Oral Sci. 2008;16: 414-9.

Véo PCR, Farias RE, Stehling RSS, Urbano ES. Tratamento cirúrgico da queilose actínica RGO. 2010;58:393-7.

De Santana SDJ, Da Costa MMC, Queiroz LM, Godoy GP, Da Silveira EJ. Actinic cheilitis: clinicopathologic profile and association with degree of dysplasia. Int J Dermatol. 2014;53:466-72.

Cavalcante AS, Anbinder AL, Carvalho YR. Actinic Cheilitis: Clinical and Histological Features. J Oral Maxillofac Surg. 2008;66:498-503.

Berking C, Herzinger T, Flaig MJ, Brenner M, Borelli C, Degitz K. The efficacy of photodynamic therapy in actinic cheilis of the lower lip; a prospective study of 15 patients. Dermatol Surgery. 2007;33:825-30.

Pirard D, Vereecken P, Mélot C, Heenen M. Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies. Arch Dermatol Res. 2005;297:185-9.

Mehregan DR, Mehregan DA, Pakiden S. Cheilitis due to treatment with simvastin. Cutis. 1998;62:197-8.

Chiller KG, Washington C, Sober AJ, Koh HK. Cancer of the skin. In: Kasper DL et al., eds . Herrisons Principales of molecular medicine. 16th ed. New York: McGraw-Hill. 2005;p.497-503.

Jadotte YT, Schwartz RA. Solar Cheilosis: an onimous precursor: part I. Diagnostic insights. J Am Acad Dermatol. 2012;66:173-84.

Warnakulasuriya S, Johnson NW, Van der waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575-80.

Nickoloff BJ, Ben-neriah Y, Pikarsky E. Inflammation and cancer : is the link as simple as we think? J Invest Dermatol. 2005;124:1275-84.

Rojas IG, Martinez A, Pineda A, Spencer ML, Jimenez M, Rudolph MI Increased mast cell density and portease content in actinic cheilitis. J Oral Pathol Med. 2004;33:567-73.

Lima GDS, Gomes AP, de Araújo LM, Salum FG. Diclofenac in hyaluronic acid gel: an alternative treatment for actinic cheilitis. J Appl Oral Sci. 2010; 18:533-7.

Wolf JE, Taylor JR, Tschen E, Kang S. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol. 2001;24: 709-13.

Fecker LF, Stockfleth E, Nindl I, Ulrich C, Forschner T, Eberle J. The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs). Br J Dermatol. 2007;156 (Suppl 3): 25-33.

Kawanishi S, Hiraku Y, Pinlaor S, Ma N. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation – related carcinogenesis. Biol Chem. 2006;387:365-72.

Berhane T, Halliday GM, Cooke B, Barnetson RS. Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans. Br J Dermatol. 2002;146:810-5.

Downloads

Published

2016-11-17

Issue

Section

Case Report